- Eli Lilly and Insitro said they have entered into three drug development deals that offer a “new paradigm” for collaborations between major pharmaceutical companies and smaller biotechs.
- Insitro, which specializes in applying machine learning to drug discovery, will get an option to license delivery technology from Lilly as…
Click here to view original postClick Here to Publish/Feature Your Company or Product News with Biotech Networks
SKULLCANDY UNVEILS “ALL LOVE” HEADPHONES AHEAD OF PRIDE MONTH IN SUPPORT OF LGBTQIA+ COMMUNITY
A Portion of Proceeds from Limited-Edition “All Love” Headphones to Support Nonprofit To Write Love on Her Arms with Funding LGBTQIA+ Mental Health Programs PARK CITY, Utah, May 30, 2023 /PRNewswire/ — Skullcandy announced today […]
GLP-1 Drug Semaglutide Linked to Reduced Muscle Strength in Mice
Semaglutide—the active compound in many GLP-1 drugs—may reduce strength even when muscle size stays the same. The findings emphasize the need for human studies that measure muscle function, not just mass. The post GLP-1 Drug […]
Suanfarma USA Reinforces Commitment to Fair Trade, Organic Ingredients
With the opening of a new facility in Utah, Suanfarma USA will rapidly cover the demand for organic ingredients for West Coast customers SALT LAKE CITY, Sept. 12, 2023 /PRNewswire/ — Suanfarma USA expands its […]
